Dr. Jody Piltz –Seymour received her medical degree from the Albert Einstein College of Medicine in New York where she also completed her Ophthalmology training and served as Chief Resident for the Department of Ophthalmology. She pursued advanced studies as a Glaucoma Fellow at the University of British Columbia in Vancouver and further training under the auspices of the National Eye Institute.
Dr. Piltz-Seymour has served as the Director of Glaucoma Services at the Scheie Eye Institute and Associate Professor of Ophthalmology for the University of Pennsylvania, with additional appointments to the Presbyterian Medical Center and Children’s’ Hospital of Philadelphia.
She is not only Board Certified but has also served as an examiner for the American Board of Ophthalmology and the Chair of the Glaucoma Section of the Ophthalmic Knowledge Assessment Program which is in charge of certifying exams for Ophthalmology.
She has been appointed to numerous University as well as national committees and is a member of numerous national and international scientific societies. In 2005 the American Academy of Ophthalmology granted her the Senior Achievement Award and she has been named to “Top Docs” in Philadelphia Magazine and “Best Doctors in America”.
Dr. Piltz-Seymour serves as a scientific reviewer for most of the major journals in Ophthalmology including the American Journal of Ophthalmology, the Archives of Ophthalmology and the Journal of Glaucoma. She has given well over 100 major lectures throughout the world at the most prestigious ophthalmology conferences. She has authored and co-authored hundreds of major research papers, abstracts, editorials, reviews and chapters providing fundamental contributions to the field of Glaucoma.
Numerous grants have recognized Dr. Piltz-Seymour’s talents as a superb clinician . She has laid the groundwork for much of the basic and clinical research which will guide the future treatment for glaucoma. She serves as the Principal Investigator for the landmark Ocular Hypertensive Treatment Study with a grant of over one million dollars from the National Institute of Health.

|